최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기ACS medicinal chemistry letters, v.12 no.2, 2021년, pp.242 - 248
Lee, Yeon Hee (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Cha, Hyeon-Min (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Hwang, Jun Yeon (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Park, So Yeong (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Vishakantegowda, Avinash G. (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Imran, Ali (Therapeutics & Biotechnology Division , Korea Research Institute of Chemical Technology , Daejeon 34114 , Republic of Korea) , Lee, Joo-Youn (Therapeutics & B) , Yi, Yoon-Sun , Jun, Sangmi , Kim, Ga Hyeon , Kang, Hyo Jin , Chung, Sang J. , Kim, Meehyein , Kim, Hyejin , Han, Soo Bong
As the spread of infections caused by hepatitis B virus (HBV) threatens public health worldwide, investigations from multiple perspectives and of various mechanisms of action are urgently required to increase the HBV cure rate. Targeting the encapsidation of the nuclear capsid protein (core protein,...
World Health Organization Hepatitis B fact sheet, 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-B (accessed July 10, 2020).
Yuen, Man‐Fung, Lai, Ching‐Lung. Treatment of chronic hepatitis B: Evolution over two decades. Journal of gastroenterology and hepatology, vol.26, no.suppl.s1, 138-143.
Fung, J., Lai, C.-L., Seto, W.-K., Yuen, M.-F.. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. The Journal of antimicrobial chemotherapy, vol.66, no.12, 2715-2725.
Craxi, Antonio, Cooksley, W.Graham. Pegylated interferons for chronic hepatitis B. Antiviral research, vol.60, no.2, 87-89.
Shaw, Tim, Bartholomeusz, Angeline, Locarnini, Stephen. HBV drug resistance: Mechanisms, detection and interpretation. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.44, no.3, 593-606.
Zoulim, Fabien, Locarnini, Stephen. Hepatitis B Virus Resistance to Nucleos(t)ide Analogues. Gastroenterology, vol.137, no.5, 1593-1608.e2.
Nassal, Michael. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut: journal of the British Society of Gastroenterology, vol.64, no.12, 1972-1984.
Allweiss, Lena, Dandri, Maura. The Role of cccDNA in HBV Maintenance. Viruses, vol.9, no.6, 156-.
Zhu, Anjing, Liao, Xinzhong, Li, Shuang, Zhao, Hang, Chen, Limin, Xu, Min, Duan, Xiaoqiong. HBV cccDNA and Its Potential as a Therapeutic Target. Journal of clinical and translational hepatology, vol.7, no.3, 1-5.
Ligat, Gaëtan, Goto, Kaku, Verrier, Eloi, Baumert, Thomas F.. Targeting Viral cccDNA for Cure of Chronic Hepatitis B. Current Hepatology Reports, vol.19, no.3, 235-244.
Liang, T. Jake, Block, Timothy M., McMahon, Brian J., Ghany, Marc G., Urban, Stephan, Guo, Ju‐Tao, Locarnini, Stephen, Zoulim, Fabien, Chang, Kyong‐Mi, Lok, Anna S.. Present and future therapies of hepatitis B: From discovery to cure. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.62, no.6, 1893-1908.
Dawood, Altaf, Abdul Basit, Syed, Jayaraj, Mahendran, Gish, Robert G.. Drugs in Development for Hepatitis B. Drugs, vol.77, no.12, 1263-1280.
Lopatin, Uri. Drugs in the Pipeline for HBV. Clinics in liver disease, vol.23, no.3, 535-555.
Zlotnick, A., Venkatakrishnan, B., Tan, Z., Lewellyn, E., Turner, W., Francis, S.. Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral research, vol.121, 82-93.
Diab, Ahmed, Foca, Adrien, Zoulim, Fabien, Durantel, David, Andrisani, Ourania. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals. Antiviral research, vol.149, 211-220.
Feng, Song, Gao, Lu, Han, Xingchun, Hu, Taishan, Hu, Yimin, Liu, Haixia, Thomas, Andrew W., Yan, Zhipeng, Yang, Song, Young, John A. T., Yun, Hongying, Zhu, Wei, Shen, Hong C.. Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection. ACS infectious diseases, vol.4, no.3, 257-277.
Yang, Li, Liu, Feifei, Tong, Xiankun, Hoffmann, Daniel, Zuo, Jianping, Lu, Mengji. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives. ACS infectious diseases, vol.5, no.5, 713-724.
Nijampatnam, Bhavitavya, Liotta, Dennis C. Recent advances in the development of HBV capsid assembly modulators. Current opinion in chemical biology, vol.50, 73-79.
Deres, Karl, Schröder, Claus H., Paessens, Arnold, Goldmann, Siegfried, Hacker, Hans Jörg, Weber, Olaf, Krämer, Thomas, Niewöhner, Ulrich, Pleiss, Ulrich, Stoltefuss, Jürgen, Graef, Erwin, Koletzki, Diana, Masantschek, Ralf N. A., Reimann, Anja, Jaeger, Rainer, Groß, Rainer, Beckermann, Bernhard, Schlemmer, Karl-Heinz, Haebich, Dieter, Rübsamen-Waigmann, Helga. Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids. Science, vol.299, no.5608, 893-896.
Delaney IV, William E., Edwards, Ros, Colledge, Danni, Shaw, Tim, Furman, Phil, Painter, George, Locarnini, Stephen. Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro. Antimicrobial agents and chemotherapy, vol.46, no.9, 3057-3060.
Hepatology Gane E. 1279A 60 2014
Na, Hyo Gyeong, Imran, Ali, Kim, Kyuneun, Han, Hong Sik, Lee, Young Jin, Kim, Myung-Jin, Yun, Chang-Soo, Jung, Young-Sik, Lee, Joo-Youn, Han, Soo Bong. Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator. ACS medicinal chemistry letters, vol.11, no.2, 166-171.
Zhou, Zheng, Hu, Taishan, Zhou, Xue, Wildum, Steffen, Garcia-Alcalde, Fernando, Xu, Zhiheng, Wu, Daitze, Mao, Yi, Tian, Xiaojun, Zhou, Yuan, Shen, Fang, Zhang, Zhisen, Tang, Guozhi, Najera, Isabel, Yang, Guang, Shen, Hong C., Young, John A. T., Qin, Ning. Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. Scientific reports, vol.7, 42374-.
Liu, Chuang, Fan, Guizhen, Wang, Zhao, Chen, Hong-Song, Yin, Chang-Cheng. Allosteric conformational changes of human HBV core protein transform its assembly. Scientific reports, vol.7, 1404-1404.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.